BIO
Price
$278.76
Change
-$3.31 (-1.17%)
Updated
Sep 24, 11:36 AM (EDT)
Capitalization
7.65B
29 days until earnings call
NVST
Price
$20.78
Change
-$0.06 (-0.29%)
Updated
Sep 24, 12:18 PM (EDT)
Capitalization
3.46B
35 days until earnings call
Interact to see
Advertisement

BIO vs NVST

Header iconBIO vs NVST Comparison
Open Charts BIO vs NVSTBanner chart's image
Bio-Rad Laboratories
Price$278.76
Change-$3.31 (-1.17%)
Volume$100
Capitalization7.65B
Envista Holdings
Price$20.78
Change-$0.06 (-0.29%)
Volume$500
Capitalization3.46B
BIO vs NVST Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. NVST commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a StrongBuy and NVST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (BIO: $282.07 vs. NVST: $20.84)
Brand notoriety: BIO and NVST are both not notable
BIO represents the Medical/Nursing Services, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIO: 67% vs. NVST: 96%
Market capitalization -- BIO: $7.65B vs. NVST: $3.46B
BIO [@Medical/Nursing Services] is valued at $7.65B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.46B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $236.51B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIO and NVST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 5 bearish.
  • NVST’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NVST is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical/Nursing Services) experienced а -0.07% price change this week, while NVST (@Pharmaceuticals: Other) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.88%. For the same industry, the average monthly price growth was +5.71%, and the average quarterly price growth was +11.37%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.28%. For the same industry, the average monthly price growth was -1.82%, and the average quarterly price growth was +9.28%.

Reported Earning Dates

BIO is expected to report earnings on Oct 23, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($7.65B) has a higher market cap than NVST($3.46B). NVST has higher P/E ratio than BIO: NVST (65.13) vs BIO (25.43). NVST YTD gains are higher at: 8.035 vs. BIO (-14.137). BIO has higher annual earnings (EBITDA): 656M vs. NVST (303M). BIO has more cash in the bank: 1.37B vs. NVST (1.11B). BIO has less debt than NVST: BIO (1.41B) vs NVST (1.6B). BIO (2.55B) and NVST (2.55B) have equivalent revenues.
BIONVSTBIO / NVST
Capitalization7.65B3.46B221%
EBITDA656M303M217%
Gain YTD-14.1378.035-176%
P/E Ratio25.4365.1339%
Revenue2.55B2.55B100%
Total Cash1.37B1.11B124%
Total Debt1.41B1.6B88%
FUNDAMENTALS RATINGS
BIO vs NVST: Fundamental Ratings
BIO
NVST
OUTLOOK RATING
1..100
5865
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8691
PRICE GROWTH RATING
1..100
5452
P/E GROWTH RATING
1..100
4746
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (73) in the null industry is in the same range as BIO (82) in the Medical Specialties industry. This means that NVST’s stock grew similarly to BIO’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as BIO (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to BIO’s over the last 12 months.

BIO's SMR Rating (86) in the Medical Specialties industry is in the same range as NVST (91) in the null industry. This means that BIO’s stock grew similarly to NVST’s over the last 12 months.

NVST's Price Growth Rating (52) in the null industry is in the same range as BIO (54) in the Medical Specialties industry. This means that NVST’s stock grew similarly to BIO’s over the last 12 months.

NVST's P/E Growth Rating (46) in the null industry is in the same range as BIO (47) in the Medical Specialties industry. This means that NVST’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIONVST
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 20 days ago
70%
Bullish Trend 20 days ago
66%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CPSM28.26-0.01
-0.05%
Calamos S&P 500 Str Alt Prt ETF-May
AOD9.39-0.01
-0.11%
abrdn Total Dynamic Dividend Fund
STXI30.02-0.07
-0.23%
Strive International Developed Mkts ETF
NULC51.73-0.31
-0.60%
Nuveen ESG Large-Cap ETF
FLCH25.15-0.30
-1.18%
Franklin FTSE China ETF

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
-0.46%
A - BIO
71%
Closely correlated
-0.31%
DHR - BIO
69%
Closely correlated
-0.39%
TMO - BIO
68%
Closely correlated
-1.10%
MTD - BIO
66%
Closely correlated
-0.08%
ILMN - BIO
64%
Loosely correlated
-2.09%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.24%
A - NVST
57%
Loosely correlated
-0.31%
MTD - NVST
56%
Loosely correlated
-0.08%
SOLV - NVST
55%
Loosely correlated
-0.50%
XRAY - NVST
55%
Loosely correlated
-2.11%
BIO - NVST
53%
Loosely correlated
-0.46%
More